159 related articles for article (PubMed ID: 34865304)
1. Gestational weight gain, appetite regulating hormones, and metformin treatment in polycystic ovary syndrome: A longitudinal, placebo-controlled study.
Molin J; Vanky E; Løvvik TS; Dehlin E; Bixo M
BJOG; 2022 Jun; 129(7):1112-1121. PubMed ID: 34865304
[TBL] [Abstract][Full Text] [Related]
2. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
[TBL] [Abstract][Full Text] [Related]
3. Gestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study.
Kent J; Dodson WC; Kunselman A; Pauli J; Stone A; Diamond MP; Coutifaris C; Schlaff WD; Alvero R; Casson P; Christman GM; Rosen RM; Hansen KR; Robinson RD; Baker V; Usadi R; Santoro N; Zhang H; Eisenberg E; Legro RS;
J Clin Endocrinol Metab; 2018 Nov; 103(11):4315-4323. PubMed ID: 30085187
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials.
Ujvari D; Trouva A; Hirschberg AL; Vanky E
BMJ Open; 2023 Nov; 13(11):e073619. PubMed ID: 37989369
[TBL] [Abstract][Full Text] [Related]
6. Leptin and Ghrelin in Excessive Gestational Weight Gain-Association between Mothers and Offspring.
Patro-Małysza J; Trojnar M; Skórzyńska-Dziduszko KE; Kimber-Trojnar Ż; Darmochwał-Kolarz D; Czuba M; Leszczyńska-Gorzelak B
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096564
[TBL] [Abstract][Full Text] [Related]
7. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy.
Glueck CJ; Goldenberg N; Wang P; Loftspring M; Sherman A
Hum Reprod; 2004 Mar; 19(3):510-21. PubMed ID: 14998944
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin.
Trouva A; Alvarsson M; Calissendorff J; Åsvold BO; Vanky E; Hirschberg AL
Front Endocrinol (Lausanne); 2022; 13():772801. PubMed ID: 35265033
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.
Sepilian VP; Crochet JR; Nagamani M
Fertil Steril; 2006 May; 85(5):1441-7. PubMed ID: 16579998
[TBL] [Abstract][Full Text] [Related]
10. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
[TBL] [Abstract][Full Text] [Related]
11. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
[TBL] [Abstract][Full Text] [Related]
12. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
Glueck CJ; Wang P; Kobayashi S; Phillips H; Sieve-Smith L
Fertil Steril; 2002 Mar; 77(3):520-5. PubMed ID: 11872206
[TBL] [Abstract][Full Text] [Related]
13. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
[TBL] [Abstract][Full Text] [Related]
14. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
15. Childbirth experiences in women with polycystic ovary syndrome: A cohort study.
Husby AE; Simpson MR; Dalbye R; Larsen M; Vanky E; Løvvik TS
Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1092-1100. PubMed ID: 38366810
[TBL] [Abstract][Full Text] [Related]
16. Does Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
Underdal MO; Stridsklev S; Oppen IH; Høgetveit K; Andersen MS; Vanky E
J Clin Endocrinol Metab; 2018 Jun; 103(6):2408-2413. PubMed ID: 29659896
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of leptin at mid-pregnancy are associated with gestational weight gain among pregnant women in Tanzania: a prospective cohort study.
Wang D; Darling AM; McDonald CR; Perumal N; Liu E; Wang M; Aboud S; Urassa W; Conroy AL; Hayford KT; Liles WC; Kain KC; Fawzi WW
BMC Pregnancy Childbirth; 2021 Oct; 21(1):675. PubMed ID: 34615489
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS.
Ryssdal M; Vanky E; Stokkeland LMT; Jarmund AH; Steinkjer B; Løvvik TS; Madssen TS; Iversen AC; Giskeødegård GF
J Clin Endocrinol Metab; 2023 Aug; 108(9):e743-e753. PubMed ID: 36916886
[TBL] [Abstract][Full Text] [Related]
19. THE ASSOCIATION OF GESTATIONAL WEIGHT GAIN AND ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH GESTATIONAL DIABETES MELLITUS.
Xu Q; Ge Z; Hu J; Shen S; Bi Y; Zhu D
Endocr Pract; 2019 Nov; 25(11):1137-1150. PubMed ID: 31414907
[No Abstract] [Full Text] [Related]
20. Gestational weight gain during the second and third trimesters and adverse pregnancy outcomes, results from a prospective pregnancy cohort in urban Tanzania.
Yang J; Wang M; Tobias DK; Rich-Edwards JW; Darling AM; Abioye AI; Pembe AB; Madzorera I; Fawzi WW
Reprod Health; 2022 Jun; 19(1):140. PubMed ID: 35710384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
